Zydus Wellness (531335) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
3 Feb, 2026Executive summary
Q3 FY26 saw strong double-digit revenue and volume growth, driven by organic brands, acquisitions, and continued e-commerce and quick commerce momentum.
Portfolio expansion included new launches in Nutralite Professional, Comfort Click, and international expansion of WeightWorld and RiteBite Max Protein.
Complan maintained its market share, Everyuth delivered double-digit YTD growth, and Sugar Free Green achieved its 19th consecutive quarter of double-digit growth.
Gross margin expanded significantly, supported by portfolio strength and new brand integration.
Adjusted PAT declined due to higher finance costs, amortization from acquisitions, and exceptional items.
Financial highlights
Q3 FY26 net sales grew 113.7% YoY to INR 9,633 million; food and nutrition segment up 134%, personal care down 1.4%.
Gross margin for Q3 FY26 was 63.3%, up 1561 bps YoY; EBITDA reached INR 610 million, up 312.2% YoY, with margin at 6.3%.
Net loss including exceptional items and non-cash amortization was INR 399 million; adjusted net loss (excluding exceptional items) was INR 333 million.
Consolidated revenue for the quarter was 9,633 million, up from 6,429 million YoY; consolidated net loss for the quarter was (399) million, compared to a profit of 64 million last year.
Standalone revenue from operations for the quarter was 1,526 million, up from 997 million YoY; standalone net profit for the quarter was 121 million.
Outlook and guidance
Annualized gross margin expected in the 60%-67% range, with Comfort Click being margin accretive.
Comfort Click expected to deliver double-digit top-line growth and 14%+ EBITDA margins; base business targeted to reach 16%-18% EBITDA margins over the next two years.
Management expects FY26 to be the bottom for PAT, with accretion from next year; integration synergies and margin efficiencies from acquisitions to support profitability.
Incremental growth anticipated from new product launches, geographic expansion, and seasonal opportunities in 2026.
Revenues and profits are typically skewed toward the first and last quarters due to seasonality.
Latest events from Zydus Wellness
- Q1 FY25 delivered 20% sales growth, margin expansion, and a debt-free balance sheet.531335
Q1 24/252 Feb 2026 - Double-digit sales growth, margin gains, and a major acquisition boost future prospects.531335
Q2 24/2515 Jan 2026 - Double-digit sales and profit growth, margin gains, and new product launches drove Q3 FY25.531335
Q3 24/259 Jan 2026 - Double-digit growth, margin gains, and digital expansion mark FY25, with major acquisition and dividend.531335
Q4 24/2520 Nov 2025 - Q1 FY26 saw 2.2% sales growth, resilient margins, and strong digital and acquisition-led gains.531335
Q1 25/2616 Nov 2025 - Q2 FY26 sales up 31% with margin gains, but net loss widened on acquisition-related costs.531335
Q2 25/266 Nov 2025